Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
Anna-Katharina MeißnerRobin GutscheNorbert GalldiksMartin KocherStephanie T JüngerMarie-Lisa EichManuel Montesinos-RongenAnna BrunnMartina DeckertChristina WendlWolfgang DietmaierRoland GoldbrunnerMaximilian I RugeCornelia MauchNils-Ole SchmidtMartin ProescholdtStefan J GrauPhilipp LohmannPublished in: Neuro-oncology (2022)
The developed radiomics classifier allows a noninvasive prediction of the intracranial BRAF V600E mutation status in patients with melanoma brain metastases with high diagnostic performance.